|

Gemcitabin Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since September 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Peking University1
  • Crescent Biopharma, Inc.1
  • Blokhin's Russian Cancer Research Center1

Indications

  • Cancer3
  • BCG-Unresponsive Bladder Cancer1
  • Biliary Tract Cancer (BTC)1
  • Locally Advanced/Metastatic Solid Tumors1
  • Non-Muscle Invasive Bladder Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.